CHINA GEWANG BIOTECHNOLOGY, INC. AND SUBSIDIARIES - Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	May 31, 2016	May 31, 2015	May 31, 2016	May 31, 2015
Income Statement
REVENUE	$ 5,437,183	$ 1,045,750	$ 6,655,281	$ 2,006,612
Cost of goods sold	(3,025,001)	(284,699)	(3,367,609)	(547,058)
Gross profit	2,412,182	761,051	3,287,672	1,459,554
OPERATING EXPENSES:
Selling and marketing	649,302	174,677	919,973	328,645
General and administrative	122,978	131,230	259,939	188,253
TOTAL OPERATING EXPENSES	772,280	305,907	1,179,912	516,898
Operating income	1,639,902	455,144	2,107,760	942,656
Other income:
Interest income	6,327	1,431	11,095	3,871
Other non-operating income			1,490
Total other income	6,327	1,431	12,585	3,871
Income before provision for income taxes	1,646,229	456,575	2,120,345	946,527
Provision for income taxes	416,553	114,623	539,969	237,610
Equity in income of investee	408,275		408,275
Net income before noncontrolling interests	1,637,951	341,952	1,988,651	708,917
Noncontrolling interest	(62,483)	(15,474)	(80,995)	(32,077)
Net income attributable to common stockholders	$ 1,575,468	$ 326,478	$ 1,907,656	$ 676,840
Earnings per common share	$ 0.03	$ 0.01	$ 0.03	$ 0.02
Weighted average shares outstanding	60,543,478	37,456,522	55,882,514	36,489,011
Comprehensive income:
Net income before noncontrolling interests	$ 1,637,951	$ 341,952	$ 1,988,651	$ 708,917
Foreign currency translation adjustment	(122,371)	25,735	(308,784)	5,558
Total comprehensive income	1,515,580	367,687	1,679,867	714,475
Comprehensive income attributable to noncontrolling interests	(72,978)	(16,760)	(82,171)	(32,355)
Net comprehensive income attributable to common stockholders	$ 1,442,602	$ 350,927	$ 1,597,696	$ 682,120